Impact Factor 4.400

The 1st most cited open-access journal in Pharmacology & Pharmacy

Retraction ARTICLE

Front. Pharmacol., 21 June 2017 | https://doi.org/10.3389/fphar.2017.00426

Retraction: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn

The Journal and Chief Editors retract the 28 July 2016 article cited above. Based on information discovered after publication and reported to Frontiers in November 2016, the article was examined, revealing image duplication in Figures 4A,B.

As this duplication breaches Frontiers guidelines and could not be sufficiently explained by the authors, the article has been retracted. The Editors acknowledge the authors' statement that these errors were the result of human error. The retraction of the article was approved by the Field Chief Editor for Frontiers in Pharmacology. The authors agree to the retraction and the notice.

Citation: Frontiers Editorial Office (2017) Retraction: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn. Front. Pharmacol. 8:426. doi: 10.3389/fphar.2017.00426

Received: 14 June 2017; Accepted: 14 June 2017;
Published: 21 June 2017.

Approved by:

Théophile Godfraind, Université Catholique de Louvain, Belgium

Copyright © 2017 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org